Omega-3 fatty acids remain central to pharmaceutical and nutraceutical strategies targeting cardiometabolic, inflammatory, and neuroprotective indications. Fish oil, rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has historically been considered the gold standard for omega-3 delivery due to direct systemic availability of long-chain fatty acids.